Purchase Order 75N95C25P00114
Award Date 9/24/25
Potential Completion Date 9/23/26
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Columbia, MD 21045, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
- This is a $23,086.75 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc., doing business as Precision Antibody. Precision Antibody is a for-profit manufacturer of goods that provides custom antibody development services to support biomedical research. This contract is not set aside for small businesses. The award supports research efforts through the...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to ACGT, Inc., a for-profit, Asian-Pacific American-owned subchapter S corporation, for the production and verification of 5 GLP-grade plasmids. The contract has a ceiling value of $27,300.00 and a period of performance ending on March 13, 2012. ACGT, Inc. is a contract research service company that has previously provided DNA sequencing, PCR DNA purification, and other...
- The National Center for Advancing Translational Sciences (NCATS) awarded a $739,894 firm fixed-price purchase order to Mriglobal (doing business as Midwest Research Institute) on September 16, 2025, for the procurement of API and diluent. The contract, which carries no set-aside designation, is scheduled for completion by September 19, 2028, and will be performed in Potomac, Maryland. Mriglobal is a Kansas City-based 501(c)(3) not-for-profit research organization with over $110 million in annual...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed price purchase order to Revvity Health Sciences, Inc. for the purchase of two reagent kits: the HTRF cAMP Gi Assay kit and the HTRF cAMP Gs Dynamic Assay kit. The total potential value of the award is $243,665.00. These kits will be used by NCATS' Tox21 group to screen a library of 10,000 compounds as part of a cross-partner project...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $18,028.80 to Reaction Biology Corporation, a self-certified small disadvantaged business. The contract, which does not have a set-aside designation, was awarded on June 5, 2019, with a completion date of December 13, 2019. Reaction Biology Corporation, a drug discovery contract research organization,...
- The National Center for Advancing Translational Sciences (NCATS) awarded a $24,150 firm fixed-price purchase order to Davos Chemical Corp. to procure analytical characterization services for a small molecule pyruvate kinase activator compound (NCGC-4932). The scope of work involves defining and characterizing the solid-state properties of the free base form of this pharmaceutical agent. This contract represents a targeted procurement supporting NCATS's mission to accelerate the translational...
- This is a firm-fixed-price delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $26,400.00 and an ultimate completion date of March 31, 2027. It is for the provision of extended stability studies of parathyroid hormone-related protein (PTH-IA) to support...
- Curia Global Inc., doing business as Amri, has been awarded a $620,125 delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity contract. The delivery order is for scale-up synthesis of APX2039, a novel GWT1 enzyme inhibitor in fungi, in support of NIH's efforts to develop new treatments for...